Leon Sebring Dure Iv, MD | |
1600 7th Ave S, Birmingham, AL 35233-1711 | |
(205) 996-7850 | |
(205) 996-7867 |
Full Name | Leon Sebring Dure Iv |
---|---|
Gender | Male |
Speciality | Pediatrics - Neurodevelopmental Disabilities |
Location | 1600 7th Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316054216 | NPI | - | NPPES |
00120302 | Medicaid | MS | |
000028836 | Medicaid | AL | |
000024391 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0008X | Pediatrics - Neurodevelopmental Disabilities | 17999 (Alabama) | Primary |
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).
AIDS Healthcare Foundation, has commended the World Health Organization (WHO) for their leadership and sincere interest in ensuring the safety of generic HIV/AIDS drugs in the developing world.
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Leon Sebring Dure Iv, MD 703 Volker Hall, Birmingham, AL 35294-0001 Ph: (205) 934-3795 | Leon Sebring Dure Iv, MD 1600 7th Ave S, Birmingham, AL 35233-1711 Ph: (205) 996-7850 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).
AIDS Healthcare Foundation, has commended the World Health Organization (WHO) for their leadership and sincere interest in ensuring the safety of generic HIV/AIDS drugs in the developing world.
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration agreement with Memorial Sloan-Kettering Cancer Center to use Sutro's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered by Memorial Sloan-Kettering for the treatment of neuroblastoma in children.
WuXi PharmaTech (Cayman) Inc. today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission.
› Verified 2 days ago
Robert Patrick Richter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 | |
Dr. Mary Orr, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Birmingham, AL 35233 Phone: 205-638-9100 Fax: 205-934-7273 | |
Roger Dean Bruce, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2660 10th Ave S, Suite 636, Birmingham, AL 35205 Phone: 205-930-2220 Fax: 205-930-2223 | |
Stephanie Berger, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 7th Ave S, Mcwane Building Suite 108, Birmingham, AL 35233 Phone: 205-638-2904 | |
Jaime Dion Mckinney, Pediatrics Medicare: Medicare Enrolled Practice Location: 703 Volker Hl, Birmingham, AL 35294 Phone: 205-934-3795 | |
Worth Littlejohn Barbour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-939-9587 | |
Timothy Todd Fleenor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5004 |